Articles dans des revues avec comité de lecture (195)

  1. 31. Javaux, C., Stordeur, P., Azarkan, M., Mascart, F., & Volant-Baeyens, D. (2016). Isolation of a thiol-dependent serine protease in peanut and investigation of its role in the complement and the allergic reaction. Molecular immunology, 75, 133-143. doi:10.1016/j.molimm.2016.05.004
  2. 32. Dirix, V., Schepers, K., Massinga-Loembé, M., Worodria, W., Colebunders, R., Singh, M., Locht, C., Kestens, L., Mascart, F., & and TB-IRIS study group, (2016). Added value of long-term cytokine release assays to detect M. tuberculosis infection in HIV-infected subjects in Uganda. Journal of acquired immune deficiency syndromes. doi:10.1097/QAI.0000000000000980
  3. 33. Palazzo, R., Carollo, M., Bianco, M., Fedele, G., Schiavoni, I., Pandolfi, E., Villani, A., Tozzi, A. E., Mascart, F., & Ausiello, C. M. (2016). Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination. The New microbiologica, 39(1), 35-47.
  4. 34. Mascart, F., & Locht, C. (2015). Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines. Expert review of vaccines, 1-13. doi:10.1586/14760584.2015.1102638
  5. 35. Smith, S. G., Smits, K., Joosten, S. A., van Meijgaarden, K. K., Satti, I., Fletcher, H. H., Caccamo, N., Dieli, F., Mascart, F., McShane, H., Dockrell, H. M., Ottenhoff, T. H. M., & TBVI TB Biomarker Working Group, (2015). Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines. PloS one, 10(9), e0138042. doi:10.1371/journal.pone.0138042
  6. 36. Delatte, B., Jeschke, J., Defrance, M., Bachman, M., Creppe, C., Calonne, E., Bizet, M., Deplus, R., Marroquí, L., Libin, M., Ravichandran, M., Mascart, F., Eizirik, D. L., Murrell, A., Jurkowski, T. P., & Fuks, F. (2015). Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress. Scientific reports, 5, 12714. doi:10.1038/srep12714
  7. 37. Smits, K., Corbiere, V., Dirix, V., Mekkaoui, L., Wyndham-Thomas, C., Libin, M., Dreesman, A., Loyens, M., Payen, M.-C., Singh, M., Locht, C., & Mascart, F. (2015). Immunological Signatures Identifying Different Stages of Latent Mycobacterium tuberculosis Infection and Discriminating Latent from Active Tuberculosis in Humans. Journal of clinical & cellular immunology, 6. doi:10.4172/2155-9899.1000341
  8. 38. Wyndham-Thomas, C., Schepers, K., Dirix, V., Mascart, F., Van Vooren, J.-P., & Goffard, J.-C. (2015). Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting. Epidemiology and infection, 1-9. doi:10.1017/S0950268815001594
  9. 39. De Rond, L., Van Els, C. A. C. M. C., Smits, K., Buisman, A.-M., Schure, R. M., Öztürk, K., Berbers, G., Sanders, E. A. M., Twillert, I. V., Carollo, M., Mascart, F., & Ausiello, C. M. (2015). Identification of pertussis-specific effector memory T cells in preschool children. Clinical and Vaccine Immunology (Print), 22(5), 561-569. doi:10.1128/CVI.00695-14
  10. 40. Schepers, K., Dirix, V., Verscheure, V., Mascart, F., Mouchet, F., Lecher, S., & Locht, C. (2015). Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis. Vaccine, 33(8), 1077-1083. doi:10.1016/j.vaccine.2014.12.011
  11. 41. Goovaerts, O., Jennes, W., Massinga-Loembé, M., Ondoa, P., Ceulemans, A., Vereecken, C., Worodria, W., Mayanja-Kizza, H., Colebunders, R., Kestens, L., Mascart, F., TB-IRIS Study Group, T., et al. (2015). Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. PloS one, 10(7), e0133924. doi:10.1371/journal.pone.0133924
  12. 42. Wyndham-Thomas, C., Dirix, V., Schepers, K., Martin, C., Hildebrand, M., Goffard, J.-C., Domont, F., Libin, M., Loyens, M., Locht, C., Van Vooren, J.-P., & Mascart, F. (2015). Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube. BMC infectious diseases, 15, 59. doi:10.1186/s12879-015-0796-0

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Suivant >>